Aviva’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$78.3M Buy
1,090,452
+31,048
+3% +$2.39M 0.13% 150
2025
Q4
$84.1M Buy
1,059,404
+55,222
+5% +$4.35M 0.14% 140
2025
Q3
$75.7M Buy
1,004,182
+60,742
+6% +$4.16M 0.14% 146
2025
Q2
$65.1M Buy
943,440
+151,885
+19% +$9.96M 0.13% 153
2025
Q1
$53.6M Buy
791,555
+110,346
+16% +$6.6M 0.13% 177
2024
Q4
$30.6M Buy
681,209
+414,008
+155% +$23.2M 0.08% 252
2024
Q3
$16.8M Sell
267,201
-34,290
-11% -$2M 0.04% 370
2024
Q2
$17.8M Sell
301,491
-59,958
-17% -$3.75M 0.05% 365
2024
Q1
$28.8M Sell
361,449
-144,538
-29% -$11M 0.09% 254
2023
Q4
$40M Buy
505,987
+129,148
+34% +$9.19M 0.14% 153
2023
Q3
$26.3M Sell
376,839
-119
-0% -$8.43K 0.11% 226
2023
Q2
$26.1M Sell
376,958
-42,242
-10% -$3.01M 0.11% 232
2023
Q1
$31.2M Sell
419,200
-44,846
-10% -$3.76M 0.14% 198
2022
Q4
$43.2M Buy
464,046
+26,936
+6% +$2.6M 0.21% 104
2022
Q3
$41.7M Buy
437,110
+7,301
+2% +$723K 0.24% 74
2022
Q2
$39.8M Buy
429,809
+46,260
+12% +$4.51M 0.21% 88
2022
Q1
$38.8M Sell
383,549
-687,314
-64% -$72.2M 0.19% 101
2021
Q4
$110M Sell
1,070,863
-95,946
-8% -$8.87M 0.46% 41
2021
Q3
$99M Buy
1,166,809
+153,205
+15% +$12.8M 0.44% 45
2021
Q2
$84.6M Buy
1,013,604
+221,008
+28% +$18.1M 0.37% 56
2021
Q1
$59.6M Sell
792,596
-75,484
-9% -$5.5M 0.29% 79
2020
Q4
$59.3M Buy
868,080
+33,397
+4% +$2.17M 0.31% 77
2020
Q3
$48.7M Sell
834,683
-13,735
-2% -$855K 0.29% 81
2020
Q2
$55.1M Sell
848,418
-11,465
-1% -$722K 0.34% 68
2020
Q1
$51M Sell
859,883
-15,204
-2% -$1.01M 0.37% 63
2019
Q4
$65M Buy
875,087
+95,987
+12% +$6.74M 0.39% 59
2019
Q3
$49.1M Buy
779,100
+177,342
+29% +$10.5M 0.33% 67
2019
Q2
$32.8M Sell
601,758
-8,122
-1% -$437K 0.23% 98
2019
Q1
$32.9M Buy
609,880
+849
+0.1% +$52.4K 0.22% 102
2018
Q4
$39.9M Sell
609,031
-22,793
-4% -$1.7M 0.3% 86
2018
Q3
$49.7M Sell
631,824
-23,473
-4% -$1.68M 0.27% 93
2018
Q2
$42.2M Sell
655,297
-8,840
-1% -$583K 0.25% 96
2018
Q1
$41.3M Sell
664,137
-15,613
-2% -$1.12M 0.25% 100
2017
Q4
$49.3M Sell
679,750
-76,360
-10% -$5.55M 0.28% 88
2017
Q3
$61.5M Buy
756,110
+11,172
+1% +$884K 0.33% 68
2017
Q2
$60M Sell
744,938
-1,790
-0.2% -$141K 0.34% 65
2017
Q1
$58.6M Sell
746,728
-210,794
-22% -$16.8M 0.34% 67
2016
Q4
$75.6M Sell
957,522
-7,416
-0.8% -$600K 0.45% 43
2016
Q3
$85.9M Buy
964,938
+18,069
+2% +$1.71M 0.54% 41
2016
Q2
$90.7M Buy
946,869
+159,518
+20% +$15.9M 0.62% 34
2016
Q1
$81.7M Buy
787,351
+131,087
+20% +$12.7M 0.61% 37
2015
Q4
$64.2M Sell
656,264
-1,626
-0.2% -$159K 0.49% 46
2015
Q3
$63.5M Sell
657,890
-65,533
-9% -$6.89M 0.53% 39
2015
Q2
$75.9M Buy
723,423
+33,401
+5% +$3.41M 0.54% 43
2015
Q1
$71.2M Buy
690,022
+85,940
+14% +$8.7M 0.49% 47
2014
Q4
$58.2M Sell
604,082
-19,575
-3% -$1.72M 0.45% 54
2014
Q3
$49.6M Sell
623,657
-9,606
-2% -$757K 0.39% 54
2014
Q2
$47.7M Sell
633,263
-1,842
-0.3% -$139K 0.36% 57
2014
Q1
$47.5M Sell
635,105
-16,559
-3% -$1.17M 0.39% 61
2013
Q4
$46.6M Sell
651,664
-117,891
-15% -$7.57M 0.39% 61
2013
Q3
$43.7M Buy
769,555
+101,414
+15% +$6.04M 0.38% 55
2013
Q2
$38.2M Buy
+668,141
New +$38.7M 0.39% 58

Other funds holding CVS

Aviva's CVS Position: Q1 2026 in Review

Aviva increased its CVS Health (CVS) stake by 2.9% in Q1 2026, buying an estimated $2.39M and bringing the position to 1,090,452 shares worth $78.3M. The position accounts for 0.13% of the portfolio, ranked #150.

Aviva first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $110M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Aviva held 1,090,452 shares of CVS Health worth $78.3M as of Q1 2026.
  • Aviva bought 31,048 CVS Health shares in Q1 2026, an estimated $2.39M.
  • CVS Health made up 0.13% of Aviva's portfolio in Q1 2026, its #150 holding.
  • Aviva first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Aviva's CVS Health position peaked at $110M in Q4 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.